Lugo Ralph A, Ballard Julie
Department of Pharmacotherapy and Pediatrics, University of Utah College of Pharmacy and School of Medicine, Salt Lake City, 84112-5820.
Respir Care. 2004 Sep;49(9):1029-34.
Albuterol aerosol is commonly administered to mechanically ventilated neonates via metered-dose inhaler (MDI) with spacer. The spacer increases the dead space in the ventilation circuit, and some institutions limit the amount of time the spacer remains in line, to minimize carbon dioxide retention and the risk of hypercarbia. However, minimizing the amount of time the spacer remains in line might also limit albuterol delivery to the patient.
To determine whether limiting the amount of time the spacer is left in line after MDI actuation significantly reduces albuterol delivery.
We conducted a bench study with a neonatal ventilator-lung model that included a Bird VIP ventilator, in a time-cycled, pressure-limited, continuous-flow mode, with settings to simulate a 1-kg infant with moderate lung disease: peak inspiratory pressure 25 cm H2O, positive end-expiratory pressure 4 cm H2O, respiratory rate 30 breaths/min, inspiratory time 0.35 s, tidal volume approximately 7 mL. The circuit was attached to a 3.0-mm inner-diameter endotracheal tube and a neonatal test lung. We tested 5 methods of MDI albuterol administration. The first 3 methods used a spacer attached to the ETT and either 5, 15, or 30 manual breaths (flow 6 L/min, respiratory rate 30 breaths/min, peak inspiratory pressure 25 cm H2O) were delivered after each MDI actuation (2 actuations). The final 2 methods used an in-line spacer (placed between the circuit Y-piece and the endotracheal tube) with the spacer kept in line for 30 or 60 s after each actuation (2 actuations). A breathing filter was placed between the ETT and test lung to trap the aerosolized albuterol.
Mean +/- SD albuterol delivery was 2.3 +/- 0.5%, 3.6 +/- 1.8%, and 5.1 +/- 1.3% after 5, 15, and 30 manual breaths, respectively (p < or = 0.05 for 30 breaths vs 5 and 15 breaths). Albuterol delivery was 3.7 +/- 1.3% when the spacer was left in line for 30 s, versus 3.7 +/- 0.6% when it was left in line for 60 s.
Limiting the time that the spacer was left in line after each MDI actuation significantly reduced albuterol delivery in our neonatal ventilator-lung model.
沙丁胺醇气雾剂通常通过带有储雾罐的定量吸入器(MDI)给予机械通气的新生儿。储雾罐会增加通气回路中的死腔,一些机构会限制储雾罐连接在回路中的时间,以尽量减少二氧化碳潴留和高碳酸血症的风险。然而,尽量缩短储雾罐连接在回路中的时间也可能会减少沙丁胺醇输送到患者体内的量。
确定在MDI启动后限制储雾罐连接在回路中的时间是否会显著减少沙丁胺醇的输送量。
我们使用一个新生儿呼吸机 - 肺模型进行了一项实验台研究,该模型包括一台Bird VIP呼吸机,采用时间切换、压力限制、持续气流模式,设置参数以模拟一名患有中度肺部疾病的1千克婴儿:吸气峰压25厘米水柱,呼气末正压4厘米水柱,呼吸频率30次/分钟,吸气时间0.35秒,潮气量约7毫升。回路连接到一根内径为3.0毫米的气管插管和一个新生儿测试肺上。我们测试了5种MDI沙丁胺醇给药方法。前3种方法使用连接到气管插管的储雾罐,每次MDI启动(2次启动)后进行5次、15次或30次手动呼吸(气流6升/分钟,呼吸频率30次/分钟,吸气峰压25厘米水柱)。最后2种方法使用在线储雾罐(放置在回路Y形接头和气管插管之间),每次启动(2次启动)后将储雾罐连接在回路中30秒或60秒。在气管插管和测试肺之间放置一个呼吸过滤器以捕获雾化的沙丁胺醇。
在进行5次、15次和30次手动呼吸后,沙丁胺醇的平均输送量分别为2.3±0.5%、3.6±1.8%和5.1±1.3%(30次呼吸与5次和15次呼吸相比,p≤0.05)。当储雾罐连接在回路中30秒时,沙丁胺醇的输送量为3.7±1.3%,而连接60秒时为3.7±0.6%。
在我们的新生儿呼吸机 - 肺模型中,每次MDI启动后限制储雾罐连接在回路中的时间会显著减少沙丁胺醇的输送量。